Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial - Huijgen, R; Abbink, E J; Bruckert, E; Stalenhoef, AF H; Imholz, BP M; Durrington, P N; Trip, M D; Eriksson, M; Visseren, FL J; Schaefer, J R; Kastelein, JJ Pfor the Triple Study Group (Clin Ther, 2010)